The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EPIK-P2: A prospective phase 2, double-blind, randomized, placebo-controlled study of alpelisib in pediatric and adult patients (Pts) with PIK3CA-related overgrowth spectrum (PROS).
 
Guillaume Canaud
Consulting or Advisory Role - Bridgebio; Fresenius; Novartis
Patents, Royalties, Other Intellectual Property - WO2017140828A1
Travel, Accommodations, Expenses - Novartis
 
Juan Carlos López Gutiérrez
Speakers' Bureau - Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Adrienne M. Hammill
Consulting or Advisory Role - Novartis
 
Lisa Weibel
Consulting or Advisory Role - Novartis; Pierre Fabre; Sanofi
 
Ghislaine Vincent
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Séverine Niglis
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Michaela Paul
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Denise M. Adams
Consulting or Advisory Role - Novartis; Venthera